Search
News
International Hematologic Conference Features UCSF Health Experts
Hematologists and oncologists from around the world will present new research and clinical findings at the American Society of Hematology’s (ASH) 64th Annual Meeting and Exposition.
Document
Cerebrovascular Neurosurgery
As one of the highest volume and most experienced surgical programs in the nation for cerebrovascular disorders, we offer a wide range of treatment options tailored to each patient, leading to safer surgeries and better outcomes.
News
Advances in Treating Colorectal Cancer With Liver Metastases
Giving new hope to potentially thousands of patients, surgeons at UC San Francisco are now providing lifesaving procedures for many colorectal cancer patients whose cancer has spread to the liver.
News
UCSF Research Instrumental in Approval of Breakthrough Diabetes Therapy
The US Food and Drug Administration (FDA) recently approved the use of a new drug Teplizumab, an immunotherapy drug which has been shown to significantly delay the onset of type 1 diabetes.
Document
Cancer Immunotherapy Toxicity Evaluation (CITE) Program
UCSF Health’s new Cancer Immunotherapy Toxicity Evaluation (CITE) Program is a valuable resource for both patient care and provider consults.
News
Killing Pancreatic Cancer with T Cells that Turbocharge Themselves
Novel Immunotherapy Pumps Out Cancer-Killing Cytokines Only Inside the Tumor
News
John de Groot, MD, Named Division Chief of Neuro-Oncology at UCSF
John F. de Groot, MD, has been named the new chief of the Division of Neuro-Oncology within the Department of Neurological Surgery at UC San Francisco.
Video
Types and Classifications of Fibroids
Dr. Jeannette Lager discusses the three types of fibroids; submucosal, intramural and subserosal.
Video
Clinical Case Reports and New mNGS-Based Technologies
Charles Chiu, MD, PhD, discusses cases where mNGS testing saved the life of a patient with undiagnosed neuroleptospirosis, and spared another patient from a potentially unnecessary liver transplant.
News
Gynecologic Cancer and Lynch Syndrome: Identifying Genetic Variants Leads to Precision Treatment
Given the increased risks associated with Lynch syndrome for gynecologic, colon and other cancers, physicians at the UCSF Gynecologic Oncology Center now approach testing, surveillance and treatment based on each patient’s individual genetic risk.
News
Artificial Intelligence and Wearable Sensors Put the Gait Lab in the Patient’s Pocket
UCSF orthopaedic surgeon Stefano Bini, MD, in collaboration with Google’s Advanced Technologies and Products (ATAP) division, is developing technology that will revolutionize how providers measure joint function and quantify joint disease. This groundbreaking approach uses cutting-edge machine-learning algorithms and data collected from inexpensive, wearable inertial sensors to accurately replicate gait lab outputs for a fraction of the cost of traditional methods, and in any context.
News
UCSF Health’s Eric Small, MD, Elected ASCO President for 2025-2026 Term
The American Society of Clinical Oncology (ASCO) has elected Eric J. Small, MD, FASCO, to serve as its president for the term beginning in June 2025.
News
New ATS Recommendation: Use Race-Neutral Equations for Pulmonary Function Test Interpretation to Improve Patient Care
An American Thoracic Society (ATS) workshop committee, which included many UCSF researchers, recently released an official statement recommending the use of race-neutral average reference equations for pulmonary function test (PFT) interpretation.
News
Drug Turns Cancer Gene Into "Eat Me" Flag for Immune System
UCSF-led study shows promising pre-clinical results in killing cancer cells resistant to current KRAS-targeted treatments.
Video
Osteoporosis and the UCSF Metabolic Bone Clinic
Edward Hsiao, MD, gives an overview of osteoporosis and metabolic bone disease treated at the UCSF Metabolic Bone Clinic, based in the UCSF Division of Endocrinology and Metabolism.
News
Personalizing Prostate Cancer Screening May Improve the Accuracy of Detection
The accuracy of prostate-specific antigen (PSA) screening for prostate cancer can be improved by accounting for genetic factors that cause changes in PSA levels that are not associated with cancer.
Video
Our Response to COVID-19: Lessons From the AIDS Epidemic
Renowned UCSF HIV/AIDS expert Paul Volberding, MD, who helped pioneer antiretroviral therapy, shares his insights on how the medical community can best respond to the current pandemic. He explains similarities and differences in the health care challenges and emphasizes the value of collaboration.
Video
Look Beyond Symptoms: When to Test for Pituitary Tumors
Tumors of the body’s “master gland” cause various symptoms – headaches, depression, sexual dysfunction, vision loss – that doctors often attribute to other conditions. UCSF endocrinology and neurosurgery specialists discuss keys to identifying patients as well as the merits of telehealth referrals in the time of COVID.
Video
Advanced Care of Subdural Hematoma in the Elderly: A Look at Embolization
Neurosurgeon Luis Savastano, MD, PhD, discusses middle meningeal artery embolization, a cutting-edge, outpatient procedure for subdural hematoma.
News
Can What Works to Treat Cancer Work for Diabetes?
To live with type 1 diabetes is to be ruled by relentless routine. Food must be carefully monitored, and the only treatment, subcutaneous insulin, is burdensome...
Video
Louder for the Patients in the Back: Making the Most of New Hearing Aid Options
Hearing loss is associated with cognitive decline, so finding solutions that help patients stay socially connected is crucial.
Video
Keeping the Eye in Sight: Ensure Proper Primary Care for Ocular Injuries
When presented with common eye issues – from corneal abrasions and foreign bodies to potentially fractured orbital bones – providers need to make prompt diagnoses, assess urgency and take steps to limit damage.
Video
Benign Prostatic Hyperplasia: Tried-and-True Versus New Treatments
Justin Ahn, MD, covers evaluation essentials for patients with signs of BPH; what to know about various medical therapies, including side effects; and the bounty of today’s surgical options.
News
UCSF Health to Mark Thirty-Five Years of Heart Transplantation in 2024
In 2024, UC Health will celebrate 35 years of performing heart transplants. Since completing their first heart transplant in March 1989, UCSF surgeons have performed nearly 600, and along the way, the health system has become a recognized leader in treating heart failure and the sixth largest program for transplants in the nation.
